 |
Sure-Silencing™
siRNA Kit |
| |
 SuperArray SureSilencing
siRNA Kits are designed to suppress the expression
of a specific gene using small interfering RNA.
The kit contains a population of multiple siRNA
duplexes specific for a target gene, siRNA negative
control and target gene-specific RT-PRC primer.
The transfection-ready siRNA population has been
pre-tested and shown to decrease the amount of corresponding
messenger RNA by at least 70 and as much as 90 percent
in HEK-293T cells. [More Info] |
| |
|
|
CASE™
: Cellular Activation of Signalling ELISA Kit |
| |
 Cellular Activation of Signaling
ELISA Kit is a cell-based protein phosphorylation
ELISA kit designed to monitor the activation of
a signal transduction pathway by assaying the extent
to which an important upstream regulatory protein
is phosphorylated. The CASE™ Kits include
a complete antibody-based detection system for determining
the ratio between a phosphorylated form of a specific
protein and the total amount of the same protein.
CASE™ kit for AKT, ERK1/2, p38 and JNK are
available.[More Info] |
| |
|
|
ICLAntibodies
vs Affinity Tags and Fusion Proteins |
| |
 Immunology Consultants Laboratory,
Inc. (ICL) offers wide range of high quality affinity
purified antibodies against affinity tags and fusion
proteins commonly used in molecular and cell biology
applications. The antibodies are suitable for western
blot, ELISA, immunoprecipitation.[More
Info] |
| |
|
|
BioLegendŪ ELISA
Max™ Set and ELISA Antibodies Pairs |
| |
 ELISA Max™ Set Standard
and ELISA Max™ Set Deluxe are specifically
engineered for accurate recovery and measurement
of analytes in complex fluids, such as serum and
plasma (as well as activated cell cultures) without
any interference by confounding serum factors, such
as heterophilic antibody or rheumatoid factor. ELISA
Max™ Set Standard includes pre-titrated capture
antibody, pre-titrated biotinylated detection antibody,
pre-titrated Avidin-HRP, conveniently-sized assay
calibration standards, and easy-to-follow instructions.
[More Info] |
| |
|
|
BioLegend® Reagents
for Immunology and Cell Biology Research |
| |
 The genomic era has given
way to realization that elucidating protein levels,
distribution, interactions, and modification are
key to understanding cell function and disease.
BioLegend develops high quality and affordable antibody
based research products covering the areas of cell
immunophenotyping, cytokine, chemokines, adhesion,
cancer research, cell-cycle analysis, and apotosis.[More Info] |
| |
|
|
MIRUS TransITŪ-TKO
siRNA Transfection Reagent |
| |
 The gold standard for siRNA
delivery, Trans IT-TKO® Transfection reagent
enables highly efficient siRNA transfection with
significant reduced level of cell damage as compared
to cationic-liposome based transfection reagents.
Also available are Trans IT-TKO® HTP-96 well
plate for siRNA screening project. Cell type sucessfully
tested includes A549, BNL.CL2, C2C12, C6, CHO-KI,
COS-7, Daoy, DB-TRG-05MG, D1-TNC1, DU145, HEK 293,
HeLa, Hepa 1-6, Hepa1cLc7, Hep G2, human astrocytes,
Jurkat, Keratinocytes (NIKS), MCF-7, Neuro-2a, NIH
3T3, PC-3, primary mouse hepatocytes, primary rat
hepatocytes, RAW 264.7, SK-N-MC, THP-1, Vero. [More Info] |
| |
|
|
MIRUS TransITŪ-siQUEST
siRNA Transfection Reagent |
| |
TransIT®-siQUEST™
Transfection Reagent enables highly efficient siRNA
transfection with significantly reduced levels of
cell damage as compared to cationic-liposome based
transfection reagents. Transfections are most effective
when carried out in complete growth media, with
no media change or serum addition required. The
unique lipopolyplex formulation offers advantages
in select cell types. Now you can choose from two
state-of-the-art siRNA transfection reagents: the
tried and tested Trans-IT-TKO® Reagent or the
new TransIT®-siQUEST™ Reagent.[More Info] |
| |
|
|
MIRUS TransITŪ
LT-1 and LT-2 Broad based Transfection Reagents |
| |
TransIT®-LT1 and LT-2
Transfection Reagent are designed to achieve high
transient and stable transfection efficiencies in
a variety of cell types, with minimal cellular toxicity.
Highest transfection efficiencies are achieved when
transfections are performed in the presence of serum-containing
media, with no media change. This robust reagent
is supplied with an optimized protocol and a ready-to-use
single vial, which allows for high reproducibility.
More than 60 cell types have been sucessfully tested
to date [More Info] |
| |
|
|
MIRUS TransITŪ
Cell Line Specific Transfection Reagents |
| |
TransIT® cell line
specific transfection reagents are developed from
MIRUS Corporation’s extensive protein, polymer
and lipid libraries to generate specialized formulations
that provide unsurpassed transfection efficiency
while maintaining minimal cellular toxicity. TransIT®
formluation optimized for Keratinocyte; 3T3; 293;
COS; CHO; HeLa and Insect cell respectively are
currenty available.[More Info] |
| |
|
|
MIRUS TransITŪ-Neural
Transfection Reagent |
| |
 The TransITŪ Neural
Transfection Reagent is a novel formulation specifically
developed to achieve superior transfection efficiency
in a wide range of neural cell types without sacrificing
cell viability. This ready-to-use reagent results
in up to 75% efficiency using pGFP as the reporter
plasmid. Highest efficiencies are achieved when
transfections are performed in the presence of serum-containing
media, with no media change.Neural cell type sucessfully
tested include C6, Daoy, DBTRG-05MG, DI-TNC1, HCN-1A,
Neuro-2a, PC-12, Secondary human astrocytes, SK-N-MC,
SVG p12 . [More Info] |
| |
|
|
MIRUS TransITŪ
- Prostate Transfection Kit |
| |
 This novel kit is specifically
optimized to provide superior transfection efficiency
in prostate cells without sacrificing cellular health.
The kit provides all the attributes of the trusted
TransITŪ Reagent line developed by MIRUS
Corp.: high efficiency, low toxicity, simplicity
of use, and reproducibility. Transfections with
the TransITŪ Reagents do not require media
changes and can be carried out in serum-containing
media. In addition, the TransITŪ - Prostate
Transfection Kit is quality control tested on ATCC
DU-145 cells. [More Info] |
| |
|
|
MIRUS TransITŪ-Jurkat
Transfection Reagent |
| |
 The TransITŪ - Jurkat
Transfection Reagent, developed by Mirus Corporation,
is a novel reagent specifically optimized to provide
superior transfection efficiency in Jurkat cells.
Jurkat cells (human T-lymphocyte; acute T-cell leukemia)
have been inherently difficult to transfect, yet
have remained a prevalent cell line in the immunological
research field. [More Info] |
| |
|
|
MIRUS TransITŪ-
in vivo Delivery System |
| |
TransIT®-in vivo Delivery
System is the first set of reagent designed specifically
for introducing nucleic acid into live mice and
rats allowing for organ specific genetic studies.
With Trans IT in vivo Gene Delivery System, high
efficiency delivey of exogenous DNA complexes into
tissue can be achieved without the use of virus.[More Info] |
| |
|
|
ACRIS® Antibodies |
| |
 More than 18,500 antibodies
against proteins in Apotosis, Cancer research, Cell
Surface Antigen, Cell Cycle, Lipid Metabolism, Neurobiology,
Signal Transduction and many more. Also available
are a comprehensive range of secondary antibodies
for Western, IHC etc. Just use our Ab Search! to
locate the antibodies of your interest.[AB Search!
Form] |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|